Long-term administration of angiotension-converting enzyme inhibitor improves the outcome of chronic heart failure in senile patients

Abstract

One hundred and sixteen senile patients (older than 65 years) with chronic heart failure (CHF) were analyzed retrospectively in order to verify if old patients with CHF would benefit from long-term (one year) angiotension-converting enzyme inhibitor (ACEI) treatment. The frequency of drugs (including ACEI, digitalis and diuretic) used was stratified into four degrees accordingly. Development of the CHF was scored with regard to relapse rate and severity of this disease. Stepwise regression analysis was applied to explore the relationship between the scored outcome of CHF and the frequency of individual drug administration. A significant relationship of the scored outcome of CHF to the frequency of ACEI usage but not to digitalis nor to diuretics was found (partial coefficient of the correlationr=0.42,P=0.002). It was concluded that the longterm administration of ACEI improves the outcome of CHF in senile patients.

Keywords

geratology / chronic heart failure / angiotension-converting enzyme inhibitor

References

[1] The SOLVD Investigators. Effect of enalpril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med, 1992, 327: 685

[2] LuzierA B, ForrestA, FeuersteinS G, et al.. Containment of heart failure hospitalizations and cost by angiotension—converting enzyme inhibitor dosage optimization. Am J Cardiol, 2000, 86: 519-519

[3] KermaniM, DuaA, GradmanA H. Underutilization and clinical benefits of angiotension-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction. Am J Cardiol, 2000, 86: 644-644

[4] PaulS D, KuntzK M, EagleK A, et al.. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med, 1994, 154: 1143-1143

[5] RogerW J, JohnstoneD E, YusufS, et al.. Quality of life among 5.025 patients with left ventricular dysfunction randomized between placebo and enalapril: the studies of left ventricular dysfunction. J Am Coll Cardiol, 1994, 23: 393-393